These findings are also supported by previous studies; where it was shown that terminal differentiation (which shares overlapping characteristics with cellular senescence) of HO-1 melanoma cells caused by combination treatment with IFN-β plus the protein kinase C activator mezerein resulted in global gene expression reductions of cell-cycle associated genes [46], [47]. The gene discussed is IFNB1; the disease is melanoma.